RedHill Biopharma (Israel) Profile

ILS 329.94  98.99%
3.03Last Month High 380.2 
3.32Trading Day  High 3.38 
Advice Valuation
October 17, 2017 updated few hours ago

RedHill Biopharma Summary

RedHill Biopharma Ltd (RDHL) is traded on Tel Aviv Stock Exchange in Israel. It is located in Tel Aviv, and employs 12 people. The company currently falls under 'Small-Cap' category with current market capitalization of 576.63 M. RedHill Biopharma Ltd has 171.82 M outstanding shares. REDHILL BIOPHARMA has accumulated about 51.07 M in cash with (37.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.3.
Check RedHill Biopharma Probability Of Bankruptcy

RedHill Biopharma Risk Profiles

Key Fundamentals

RedHill Biopharma Against Markets

Current Ratings  

RedHill Biopharma 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
< 45% 
RedHill Biopharma Ltd., a biopharmaceutical company, primarily focuses on the development and commercialization of late clinicalstage, proprietary, and orallyadministered small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, and cancer. more
NameRedHill Biopharma Ltd
Macroaxis Advice
InstrumentIsrael Stock Stocks Directory
Business AddressTel Aviv,
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
Contact Number972 3 541 3131
CurrencyILS - Israeli Shekel


RedHill Biopharma Corporate Directors
Ofer Tsimchi Director
Shmuel Cabilly Director
Kenneth Reed Director, Ph.D


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas